Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Suven Pharmaceuticals Ltd. ( (IN:COHANCE) ) has shared an update.
Cohance Lifesciences has responded to a query from the National Stock Exchange of India regarding a significant increase in trading volumes in its shares. The company stated that there is no undisclosed information or pending announcement under SEBI disclosure norms that could explain the volume spike and that the activity appears to be purely market-driven.
Management emphasized that all unpublished price sensitive information is being disclosed in compliance with regulatory requirements and that there are no corporate developments known to the company that would materially affect the price or volume behavior of its stock. The clarification aims to reassure investors and regulators about the transparency of the company’s disclosures and the integrity of trading in its shares.
More about Suven Pharmaceuticals Ltd.
Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, operates in the Indian lifesciences and pharmaceuticals sector. The company is listed on the National Stock Exchange of India under the symbol COHANCE and is subject to SEBI’s Listing Obligations and Disclosure Requirements Regulations, 2015.
Average Trading Volume: 180,951
Technical Sentiment Signal: Sell
Current Market Cap: 144.7B INR
For an in-depth examination of COHANCE stock, go to TipRanks’ Overview page.